Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Impax Laboratories Inc (IPXL) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Impax Laboratories Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1003642.
Total stock buying since 2014: $0.
Total stock sales since 2014: $15,959,221.
Total stock option exercises since 2014: $3,219,933.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2017 | 0 | $0 | 2,687 | $43,046 | 0 | $0 |
| 2016 | 0 | $0 | 10,092 | $230,198 | 23,500 | $153,925 |
| 2015 | 0 | $0 | 118,504 | $4,956,699 | 163,500 | $2,259,575 |
| 2014 | 0 | $0 | 398,201 | $10,729,278 | 65,500 | $806,433 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2017-05 | 0 | $0 | 2,687 | $43,046 | 0 | $0 |
| 2016-08 | 0 | $0 | 10,092 | $230,198 | 20,000 | $131,000 |
| 2016-03 | 0 | $0 | 0 | $0 | 3,500 | $22,925 |
| 2015-09 | 0 | $0 | 12,457 | $540,688 | 9,000 | $58,950 |
| 2015-08 | 0 | $0 | 106,047 | $4,416,011 | 81,000 | $1,505,830 |
| 2015-03 | 0 | $0 | 0 | $0 | 73,500 | $694,795 |
| 2014-09 | 0 | $0 | 0 | $0 | 53,000 | $660,210 |
| 2014-06 | 0 | $0 | 100,000 | $2,838,400 | 0 | $0 |
| 2014-05 | 0 | $0 | 298,201 | $7,890,878 | 12,500 | $146,223 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-31 | Nestor Michael (President, Impax Specialty) | Sale | 1,130 | 15.00 | 16,950 |
| 2017-05-17 | Nestor Michael (President, Impax Specialty) | Sale | 857 | 16.48 | 14,119 |
| 2017-05-12 | Nestor Michael (President, Impax Specialty) | Sale | 700 | 17.11 | 11,977 |
| 2016-08-15 | Benet Leslie Z | Sale | 10,092 | 22.81 | 230,198 |
| 2016-08-15 | Benet Leslie Z | Option Ex | 20,000 | 6.55 | 131,000 |
| 2016-03-14 | Benet Leslie Z (Director) | Option Ex | 3,500 | 6.55 | 22,925 |
| 2015-09-11 | Schlossberg Mark A (SVP and General Counsel) | Sale | 7,457 | 43.30 | 322,888 |
| 2015-09-10 | Nestor Michael (President, Impax Pharm.) | Sale | 5,000 | 43.56 | 217,800 |
| 2015-09-01 | Benet Leslie Z (Director) | Option Ex | 9,000 | 6.55 | 58,950 |
| 2015-08-31 | Fleming Nigel (Director) | Sale | 29,166 | 41.02 | 1,196,389 |
| 2015-08-31 | Fleming Nigel (Director) | Option Ex | 23,000 | 19.73 | 453,790 |
| 2015-08-31 | Benet Leslie Z (Director) | Sale | 20,000 | 40.92 | 818,400 |
| 2015-08-31 | Benet Leslie Z (Director) | Option Ex | 20,000 | 21.53 | 430,620 |
| 2015-08-31 | Markbreiter Michael (Director) | Sale | 20,000 | 41.39 | 827,800 |
| 2015-08-31 | Markbreiter Michael (Director) | Option Ex | 20,000 | 20.60 | 412,000 |
| 2015-08-28 | Markbreiter Michael (Director) | Sale | 8,000 | 42.48 | 339,840 |
| 2015-08-28 | Markbreiter Michael (Director) | Option Ex | 8,000 | 17.99 | 143,920 |
| 2015-08-27 | Schlossberg Mark A (SVP and General Counsel) | Sale | 4,649 | 43.41 | 201,813 |
| 2015-08-27 | Terreri Peter R (Director) | Sale | 4,833 | 43.93 | 212,313 |
| 2015-08-26 | Markbreiter Michael (Director) | Sale | 10,000 | 42.78 | 427,800 |
| 2015-08-26 | Markbreiter Michael (Director) | Option Ex | 10,000 | 6.55 | 65,500 |
| 2015-08-25 | Markbreiter Michael (Director) | Sale | 9,399 | 41.67 | 391,656 |
| 2015-03-25 | Hsu Larry (Director) | Option Ex | 73,500 | 9.45 | 694,795 |
| 2014-09-30 | Hsu Larry (Director) | Option Ex | 23,000 | 9.27 | 213,210 |
| 2014-09-09 | Hsu Larry (Director) | Option Ex | 30,000 | 14.90 | 447,000 |
| 2014-06-06 | Hsu Larry (Director) | Sale | 50,000 | 28.52 | 1,425,950 |
| 2014-06-05 | Hsu Larry (Director) | Sale | 50,000 | 28.25 | 1,412,450 |
| 2014-05-27 | Terreri Peter R (Director) | Sale | 3,000 | 28.00 | 84,000 |
| 2014-05-22 | Hsu Larry (Director) | Sale | 50,000 | 27.22 | 1,360,850 |
| 2014-05-21 | Hsu Larry (Director) | Sale | 3,800 | 26.53 | 100,825 |
| 2014-05-20 | Terreri Peter R (Director) | Sale | 666 | 26.07 | 17,362 |
| 2014-05-19 | Terreri Peter R (Director) | Sale | 950 | 26.03 | 24,728 |
| 2014-05-16 | Fleming Nigel (Director) | Sale | 1,900 | 25.72 | 48,868 |
| 2014-05-13 | Terreri Peter R (Director) | Sale | 666 | 26.70 | 17,782 |
| 2014-05-12 | Fleming Nigel (Director) | Sale | 1,333 | 26.58 | 35,435 |
| 2014-05-08 | Markbreiter Michael (Director) | Sale | 1,000 | 26.85 | 26,850 |
| 2014-05-08 | Markbreiter Michael (Director) | Option Ex | 1,000 | 6.55 | 6,550 |
| 2014-05-07 | Markbreiter Michael (Director) | Sale | 8,649 | 26.34 | 227,857 |
| 2014-05-07 | Markbreiter Michael (Director) | Option Ex | 8,649 | 13.99 | 120,999 |
| 2014-05-06 | Fleming Nigel (Director) | Sale | 4,000 | 26.34 | 105,360 |
| 2014-05-06 | Hsu Larry (Director) | Sale | 219,386 | 26.28 | 5,765,464 |
| 2014-05-06 | Markbreiter Michael (Director) | Sale | 2,851 | 26.48 | 75,497 |
| 2014-05-06 | Markbreiter Michael (Director) | Option Ex | 2,851 | 6.55 | 18,674 |
Insider trading activities including stock purchases, stock sales, and option exercises of IPXL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Impax Laboratories Inc (symbol IPXL, CIK number 1003642) see the Securities and Exchange Commission (SEC) website.